Devyser Diagnostics AB (publ) (STO: DVYSR)
Sweden
· Delayed Price · Currency is SEK 126.50
-0.50 (-0.39%)
Oct 4, 2024, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 2.09 billion as of October 4, 2024. Its market cap has increased by 90.31% in one year.
Market Cap
2.09B
Enterprise Value
1.95B
Revenue
196.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
126.50
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 2.09B, an increase of 54.27%. That is a compound annual growth rate of 16.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 4, 2024 | 2.09B | 62.92% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,475.34B |
| Swedish Orphan Biovitrum AB (publ) | 104.27B |
| Getinge AB (publ) | 58.75B |
| Sectra AB (publ) | 54.52B |
| Camurus AB (publ) | 38.78B |
| Vitrolife AB (publ) | 31.76B |
| Medicover AB (publ) | 27.66B |
| Elekta AB (publ) | 27.03B |